Canopy Growth Corporation Rises Almost 16% On Positive Cannabis Outlook

Canopy Growth Corporation (CGC) rose almost 16% for the day on positive news of Cannabis as a whole.

Two stories stood out today. Firstly, New York Marijuana regulators have approved  15 licenses to New York businesses, bringing NY one step closer to selling recreational marijuana. These processors are the first to be able to take marijuana grown by NY farmers and turn it into cannabis products.

The second story is that North Dakota’s cannabis petition has been approved for the November Ballot. North Dakota voters will be deciding whether or not to legalize cannabis.

The cannabis market in the U.S. is expanding and is exciting investors in the cannabis space.

About Canopy Growth Corporation

Canopy Growth (TSX: WEED) (NASDAQ: CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, Canopy Growth offers product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Canopy Growth’s global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through Canopy Growth’s award-winning Tweed and Tokyo Smoke banners, Canopy Growth reaches its adult-use consumers and has built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp derived CBD products to the United States through its First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.

 

Share this article:

Disclaimer

This communication was produced by Prism MarketView, an affiliate of PCG Advisory Inc., (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PCG” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy…

Share this article:
Read Full Disclaimer

Share This Article

 

About the Author

Canopy Growth Corporation Rises Almost 16% On Positive Cannabis Outlook

Prism MarketView